Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03707522 · ClinicalTrials.gov registry record · NA
Growth Mindset Psychoeducation for Modifiable Risk Factors for CMD
A NA study, sponsored by University of Nevada, Reno.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
NCT03707522: Completed NA study, sponsored by University of Nevada, Reno.
NCT03707522 is a NA study that has completed, run by University of Nevada, Reno. The registered enrollment target is 162 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03707522, a NA study, has completed, sponsored by University of Nevada, Reno.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
Study Summary
The present study aims to determine the effect of presenting psychoeducation emphasizing "growth-mindset," and information on modifiable risk factors (e.g., social contact, physical activity) on engagement with modifiable risk factors. The investigators hypothesize that psychoeducation emphasizing that mental health is malleable will increase the participant's engagement with risk factors outlined in the intervention.
Primary Outcome
9-item questionnaire associated containing one item for each symptom of MDD as specified by the DSM. Items consist of a 4-point Likert scale (0="Not at all" to 3="Nearly every day"). Minimum score is 0, maximum score is 27. Higher scores indicate greater depression severity.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Growth mindset
- BEHAVIORAL Modifiable risk factor (MRF) information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2018-12-21 |
| Phase | NA |
What the finished NCT03707522 record still lists
NCT03707522 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT03707522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03707522 about?
NCT03707522 is a clinical study titled "Growth Mindset Psychoeducation for Modifiable Risk Factors for CMD". The present study aims to determine the effect of presenting psychoeducation emphasizing "growth-mindset," and information on modifiable risk factors (e.g., social contact, physical activity) on engagement with modifiable risk factors. The investigators hypothesize that psychoeducation emphasizing t...
What is the current status of trial NCT03707522?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2018-06-19. Estimated completion is 2018-12-21.
What interventions are being tested in trial NCT03707522?
The interventions under investigation include: Control (BEHAVIORAL), Growth mindset (BEHAVIORAL), Modifiable risk factor (MRF) information (BEHAVIORAL).
Who is sponsoring clinical trial NCT03707522?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03707522's enrollment target sits among peer trials
162 627th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI